Your browser doesn't support javascript.
loading
Pathological Characteristics of Both Tumors in Bifocal and Bicentric Breast Cancer.
Mosbah, Rabab; Rouzier, Roman; Guinebretière, Jean-Marc; Falcou, Marie-Christine; Stevens, Denise; Héquet, Delphine.
Afiliação
  • Mosbah R; Department of Surgical Oncology, René Huguenin Center, St Cloud, France.
  • Rouzier R; Department of Surgical Oncology, René Huguenin Center, St Cloud, France Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, Montigny-le-Bretonneux, France.
  • Guinebretière JM; Department of Pathology, René Huguenin Center, St Cloud, France.
  • Falcou MC; Department of Biostatistics, Curie Institute, Paris, France.
  • Stevens D; Public Health Curie Institute, René Huguenin Center, St Cloud, France.
  • Héquet D; Department of Surgical Oncology, René Huguenin Center, St Cloud, France Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, Montigny-le-Bretonneux, France delphine.hequet@gmail.com.
Anticancer Res ; 35(9): 5111-6, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26254415
ABSTRACT

AIM:

The objective of the present study was to describe the biological characteristics of each lesion in patients with bifocal/bicentric (BF/BC) breast cancer. PATIENTS AND

METHODS:

We retrospectively reviewed the charts of 205 patients diagnosed with BF/BC cancer. The degree of concordance between the two lesions was assessed using Pearson product-moment correlation coefficients.

RESULTS:

A total of 205 patients were included. Both tumors displayed the same histological type in 182 patients (89%). The same grade was found for both tumors in 178 of the cases (96.7% and 100% for grade 3 lesions). Immunohistochemical concordance between the two tumors was excellent, with correlation coefficients of 0.98, 0.96 and 0.99 for estrogen receptors (ER), progesterone receptors (PR) and Ki67, respectively. Human Epidermal growth factor Receptor 2 (HER2) status was available for both tumors in 177 cases (86%), with a perfect concordance. We did not find any differences in molecular sub-type between tumor foci.

CONCLUSION:

Immunohistochemistry should be performed only on the main tumor in cases of BF/BC cancer.
Assuntos
Palavras-chave
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França